Research field (2):
Digestive surgery
, Medical biochemistry
Research keywords (3):
癌抑制遺伝子
, 幹細胞
, 食道
Papers (56):
Akira Shimomura, Teruki Hagiwara, Kazuhiko Yamada, Chizu Yokoi, Masayoshi Terayama, Kyoko Nohara, Toru Igari, Yuki I. Kawamura. Induction of Kallikrein-Related Peptidase 13 and TET2/3 by Anticancer Drugs and Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma After Preoperative Treatment. Annals of Surgical Oncology. 2024. 31. 1. 251-261
Ryusuke Sumiya, Masayoshi Terayama, Teruki Hagiwara, Kazuaki Nakata, Keigo Sekihara, Satoshi Nagasaka, Hideki Miyazaki, Toru Igari, Kazuhiko Yamada, Yuki I Kawamura. Loss of GSTO2 contributes to cell growth and mitochondria function via the p38 signaling in lung squamous cell carcinoma. Cancer science. 2022. 113. 1. 195-204
Naoki Enomoto, Kazuhiko Yamada, Masayoshi Terayama, Daiki Kato, Shusuke Yagi, Hitomi Wake, Nobuyuki Takemura, Tomomichi Kiyomatsu, Norihiro Kokudo. Current status of immune checkpoint inhibitor therapy for advanced esophageal squamous cell carcinoma. Global health & medicine. 2021. 3. 6. 378-385
The characterization of the function of glutathione S-transferase omega 2 (GSTO2) indicated the presence of putative quiescent stem cells in human esophagus
(Digestive Disease Week 2019)
GSTO2, a novel tumor suppressor gene, regulates ERK signaling pathway in esophageal squamous cell carcinoma
(日本癌学会 2018)
Decreased expression of PRSS27 in esophageal squamous cell carcinoma
(ISDE 2018)
85歳以上食道癌症例における治療法選択および術前リスク評価の検討
(日本食道学会 2018)
Glutathione S-transferase omega 2 (GSTO2) is a novel tumor suppressor gene in human esophageal squamous cell carcinoma
(Digestive Disease Week 2018)